There’s a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on OptimizeRx Corporation (OPRX) and Liveperson (LPSN) with bullish sentiments.
OptimizeRx Corporation (OPRX)
B.Riley FBR analyst Andrew D’silva maintained a Buy rating on OptimizeRx Corporation yesterday and set a price target of $20. The company’s shares opened today at $13.16.
D’silva said:
“Buy-rated OptimizeRx Corporation (OPRX) reports 4Q18 results AMC on Tuesday, 2/26, and will hold a conference call at 4:30PM ET the same day. The dial-in and conference ID numbers are 888.394.8218 and 7188619, respectively. We are comfortable with our estimates from our last update, as we are modeling sales to be largely flat sequentially, despite the company (1) indicating Q/Q revenue growth throughout 2018, (2) likely being able to benefit from its 4Q18 acquisition of 4Q historically being the company’s seasonally strongest quarter. We believe consensus estimates, which call for slightly more aggressive sales figures, are reasonable/beatable as well. Although, we believe it’s important to note that OPRX has not provide adj.”
According to TipRanks.com, D’silva is a 4-star analyst with an average return of 11.1% and a 46.5% success rate. D’silva covers the Healthcare sector, focusing on stocks such as Cumberland Pharmaceuticals Inc., EyePoint Pharmaceuticals Inc, and Imprimis Pharmaceuticals.
OptimizeRx Corporation has an analyst consensus of Moderate Buy, with a price target consensus of $20.
See today’s analyst top recommended stocks >>
Liveperson (LPSN)
In a report released today, Zach Cummins from B.Riley FBR reiterated a Buy rating on Liveperson, with a price target of $32. The company’s shares opened today at $25.73, close to its 52-week high of $28.
Cummins commented:
“After the market close on 2/21, LivePerson (LPSN) reported strong 4Q results: Revenues exceeded our estimate and consensus’ while adjusted EBITDA were slightly above consensus and in line with our estimate. More importantly, contract signings set a new record during the quarter, as LPSN saw strength in both the enterprise, where the company signed several seven-figure contracts, and the mid-market/SMB, which generated record demand after LPSN increased its focus on selling conversational commerce to smaller businesses. The stickiness of LPSN’s solutions was further highlighted by its ~90% retention rate across the B2B segment, and the even higher mid-90%s renewal rate amongst enterprise customers.”
According to TipRanks.com, Cummins is a 1-star analyst with an average return of -0.4% and a 53.7% success rate. Cummins covers the Technology sector, focusing on stocks such as ServiceSource International Inc, American Software, and ChannelAdvisor.
Currently, the analyst consensus on Liveperson is a Strong Buy with an average price target of $32, representing a 24.4% upside. In a report released today, Oppenheimer also reiterated a Buy rating on the stock with a $33 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
